✦ LIBER ✦

Preparation and biodistribution of yttrium-90 Lipiodol in rats following hepatic arterial injection

✍ Scribed by Shyh-Jen Wang; Wan-Yu Lin; Min-Nan Chen; Lie-Hang Shen; Zei-Tsan Tsai; Gann Tinge

Book ID: 105063316
Publisher: Springer
Year: 1995
Tongue: English
Weight: 439 KB
Volume: 22
Category: Article
ISSN: 0340-6997
DOI: 10.1007/bf01081518

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Biodistribution of Lipiodol following he

Biodistribution of Lipiodol following hepatic arterial injection

✍ Mr. R. E. Hind; M. Loizidou; S. Perring; J. Fleming; V. Batty; S. Birch; I. Tayl 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 357 KB

Preparation and biodistribution of rheni

Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection

✍ Tsai-Yueh Luo; Bor-Tsung Hsieh; Shyh-Jen Wang; Wan-Yu Lin; Te-Wei Lee; Lie-Hang 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Development and biodistribution of188Re-

Development and biodistribution of188Re-SSS lipiodol following injection into the hepatic artery of healthy pigs

✍ E. Garin; N. Noiret; C. Malbert; N. Lepareur; A. Roucoux; S. Caulet-Maugendre; A 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 206 KB

Analysis of the distribution of intra-ar

Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy

✍ Campbell, Andrew M; Bailey, Ian H; Burton, Mark A 📂 Article 📅 2000 🏛 Institute of Physics 🌐 English ⚖ 315 KB

236 Hepatic arterial 90yttrium microsphe

236 Hepatic arterial 90yttrium microspheres therapy and follow-up in 102 patients with unresectable hepatocellular carcinoma (HCC)

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Biodistribution and safety assessment of

Biodistribution and safety assessment of AAV2-GAD following intrasubthalamic injection in the rat

✍ Helen L. Fitzsimons; Veronique Riban; Ross J. Bland; Jennifer L. Wendelken; Chri 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

## Abstract ## Background The steps necessary to translate promising new biological therapies to the clinic are poorly documented. For gene therapy, there are unique aspects that need to be addressed in biodistribution studies. Notably, the spread of the vector beyond the intended target cells or